“Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated With JAK Inhibitor Tofacitinib Versus TNF Inhibitors: A Systematic Review, Meta Analysis, and Meta Regression”. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, Dec. 2025, p. 4, https://doi.org/10.53366/jimki.vi.949.